Intrauterine Lidocaine for Laminaria

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Abortion, InducedPain Management
Interventions
DRUG

Lidocaine

100mg of liquid lidocaine, single dose, instilled into the uterine cavity via a flexible trans-cervical catheter immediately prior to laminaria insertion.

DRUG

Normal Saline

5mL of normal saline, instilled into the uterus via a flexible trans-cervical catheter immediately prior to laminaria insertion.

Trial Locations (1)

27599

University of North Carolina, Chapel Hill, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT01541293 - Intrauterine Lidocaine for Laminaria | Biotech Hunter | Biotech Hunter